If you own or operate one of the estimated 1,500 ketamine clinics in the U.S. that provides cutting-edge Ketamine-Assisted Psychotherapy (KAP) to treat...
The study is expected to cost C$2.7 million and will run for three months. The post Cantheon Provides Funding to Albert Labs for Psilocybin Drug Development...
In an effort to raise funding for commercialization of MDMA-assisted therapy, MAPS partnered with an investment bank to sell equity in its Public Benefit...
Liontown Resources (ASX: LTR) said on Tuesday that it had rejected a non-binding indicative approach from top lithium producer Albemarle The post Why Did...
Artificial intelligence (AI) is becoming increasingly popular as more applications are found and new technology is introduced widely. There are so many...
With uncertainty in the financial systems, many psychedelic companies are seeing their stock prices plummet. The post It’s Survival of the Fittest among...
The company spent more money on research and cut down on overhead costs. The post Atai Life Sciences Losses Shrunk in 2022 Amid Restructuring Bid appeared...
The article Psychedelic Medicine PAC (Political Action Committee) Launches in Washington was originally published on Microdose. “A political action...
The end of the COVID-19 public health emergency could create unsurmountable hurdles. The post Psychedelic Therapy Industry Reels After Major Clinic Closures...
Source: Streetwise Reports 03/21/2023 Treating traumatic brain injury with alternative pharmaceuticals is delicate work. Now one Canadian...